Dr. Michael Hier, JGH Chief of Otolaryngology – Head and Neck Surgery, has been promoted to Full Professor at McGill University.
New book examines how Sheila Kussner and Hope & Cope forged a breakthrough in supporting cancer patients.
Virtual reality goggles, available from Hope & Cope volunteers, are now helping patients pass the time during lengthy chemotherapy sessions.
Anti-cancer treatment is now under way with a highly sophisticated and versatile linear accelerator that’s newly installed at the JGH.
Certain brain cells may be inherently vulnerable to mutations that cause fatal brain tumours in children, says a study co-led by an LDI researcher.
Artwork by a teenage artist, inspired by her mother’s battle with lung cancer, is going on display at the JGH.
Dr. Emily Kay-Rivest has joined the JGH Department of Otolaryngology-Head and Neck Surgery as a specialist in ear and skull base surgery.
Although exercise is recognized as being good for cancer patients, hematologist Dr. Nathalie Johnson is taking a closer look at how it helps those with lymphoma.
A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.
Dr. Robin Billick, JGH Chief of Dermatology, is being honoured by the Israel Cancer Research Fund for decades of service in diagnosing cancer and saving lives.